We are investigating the genetics of a large family with an autosomal dominant form of hereditary distal myopathy. This slowly progressive myopathy begins during early adulthood in the distal leg muscles, producing a gait disturbance. Cardiomyopathy is also present in most affected family members, manifesting itself as conduction block or congestive heart failure. Histologically, an accumulation of the protein, desmin, occurs in the subsarcolemmal spaces of myofibers. We have performed linkage analyses of this family, and have mapped the location of the gene causing the myopathy to human chromosome 2q33. The gene is within a 17-cM segment of chromosome 2q bounded by the DNA markers D2S2248 and D2S401. The best candidate gene for this myopathy is desmin.

Keywords:
Distal myopathy, Desmin, Linkage analysis
1.
Griggs RC, Markesbery WR: Distal myopathies; in Engel AG, Franzini-Armstrong C (eds): Myology, ed 2. McGraw-Hill, New York, 1994, pp 1246–1257.
2.
Barohn RJ, Amato JJ, Griggs RC: Overview of distal myopathies: From the clinical to the molecular. Neuromuscul Disord 1998;8:309–316.
3.
Miyoshi K, Kawai H, Iwasa M, Kusaka K, Nishino H: Autosomal recessive distal muscular dystrophy as a new type of progressive muscular dystrophy: Seventeen cases in eight families including an autopsied case. Brain 1986;109:31–54.
4.
Welander L: ‘Myopathia distalis tarda hereditaria: 249 examined cases in 72 pedigrees. Acta Med Scand 1951;141(suppl 265):1–124.
5.
Markesbery WR, Griggs RC, Leach RP, Lapham LW: Late onset hereditary distal myopathy. Neurology 1974;24:127–134.
6.
Barohn RJ, Miller RG, Griggs RC: Autosomal recessive distal dystrophy. Neurology 1991;41:1365–1370.
7.
Fardeau M, Godet-Gullain J, Tome FMS, Collin H, Gaudeau S, Boffety C, Vernant P: Une nouvelle affection musculaire familiale, définie par l’accumulation intrasarcoplasminique d’un matériel granulo-filamentaire dense en microscopie électronique. Rev Neurol (Paris) 1978;134:411–425.
8.
Edstrom L, Thornell L-E, Eriksson A: A new type of hereditary distal myopathy with characteristic sarcoplasmic bodies and intermediate (skeletin) filaments. J Neurol Sci 1980;47:171–190.
9.
Helliwell TR, Green ART, Green A, Edwards RHT: Hereditary distal myopathy with granulo-filamentous cytoplasmic inclusions containing desmin, dystrophin, and vimentin. J Neurol Sci 1994;124:174–187.
10.
Goebel HH: Desmin-related neuromuscular disorders. Muscle Nerve 1995;18:1306–1320.
11.
Goebel HH: Desminopathies; in Emery AEH (ed): Neuromuscular Disorders: Clinical and Molecular Genetics. J Wiley & Sons, Chichester, 1998, pp 217–246.
12.
Goldfarb LG, Park K-Y, Cervenakova L, Gorokhova S, Lee H-S, Vasconcelos O, Nagle JW, Seminoo-Mora S, Sivakumar K, Dalakas DC: Missense mutations in desmin associated with familial cardiac and skeletal myopathy. Nat Genet 1998;19:402–403.
13.
Vicart P, Caron A, Guicheney P, Li Z, Prevost MC, Faure A, Chateau D, Chapon F, Tome F, Dupret J-M, Paulin D, Fardeau M: A missense mutation in the αB-crystallin chaperone gene causes a desmin-related myopathy. Nat Genet 1998;20:92–95.
14.
Muñoz-Marmol AM, Strasser G, Isamat M, Coulombe PA, Yang Y, Roca X, Vela E, Mate JL, Coll J, Fernandez-Figueras MT, Navas-Palacios JJ, Ariza A, Fuchs E: A dysfunctional desmin mutation in a patient with severe generalized myopathy. Proc Natl Acad Sci USA 1998;95:11312–11317.
15.
Milhorat AT, Wolff HG: Studies in diseases of muscle. XIII. Progressive muscular dystrophy of atrophic distal type; report of a family; report of autopsy. Arch Neurol Psychiatry 1943;49:641–654.
16.
Horowitz SH, Schmalbruch H: Autosomal dominant distal myopathy with desmin storage: A clinicopathologic and electrophysiologic study of a large kinship. Muscle Nerve 1994;17:151–160.
17.
Sambrook J, Fritsch EF, Maniatis T: Molecular Cloning: A Laboratory Manual, ed 2. Cold Spring Harbor, Cold Spring Harbor Laboratory, Press, 1989.
18.
Ott J: A computer program for linkage analysis of general human pedigrees. Am J Hum Genet 1976;28:528–529.
19.
O’Connell JR, Weeks DE: The VITESSE algorithm for rapid exact multilocus linkage analysis via genotype set-recording in fuzzy inheritance. Nat Genet 1995;11:402–408.
20.
Dib C, Faure S, Fizames C, Samson D, Drouot N, Vignal A, Milleasseau P, Marc S, Hazan J, Seboun E, Lathrop M, Gyapay G, Morissette J, Weissenbach J: A comprehensive genetic map of the human genome based on 5,264 microsatellites. Nature 1996;380:152–154.
21.
Laing NG, Laing BA, Meredith C, Wilton SD, Robbins P, Honeyman K, Dorosz S, Kozman H, Mastaglia FL, Kakulas BA: Autosomal dominant distal myopathy: Linkage to chromosome 14. Am J Hum Genet 1995;56:422–427.
22.
Beggs AH, Phillips HA, Kozman H, Mulley JC, Wilton SD, Kunkel LM, Laing NG: A (CA)n repeat polymorphism for the human skeletal muscle alpha-actinin gene ACTN2 and its localization on the linkage map of chromosome 1. Genomics 1992;13:1314–1315.
23.
Viegas-Pequignot E, Lin LZ, Dutrillaux B, Apiou F, Paulin D: Assignment of human desmin gene to band 2q35 by nonradioactive in situ hybridization. Hum Genet 1989;83:33–36.
24.
Deloukas P, Schuler GD, Gyapay G, Beasley EM, Soderlund C, Rodriguez-Tome P, Hui L, Matise TC, McKusick KB, Beckmann JS, Bentolila S, Bihoreau M, Birren BB, Browne J, Butler A, Castle AB, Chiannilkulchai N, Clee C, Day PJ, Dehejia A, Dibling T, Drouot N, Duprat S, Fizames C, Bentley DR, et al.: A physical map of 30,000 human genes. Science 1998;282:744–746.
25.
Vicart P, Dupret J-M, Hazan J, Li Z, Gyapay G, Krishamoorthy R, Weissenbach J, Fardeau M, Paulin D: Human desmin gene: cDNA sequence, regional localization and exclusion of the locus in a familial desmin-related myopathy. Hum Genet 1996;98:422–429.
© 2000 S. Karger AG, Basel
2000
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.